全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Relation between Endothelial Protein C Receptor Gene Polymorphisms rs867186 and rs9574, and the Risk of Deep Vein Thrombosis in Sudanese

DOI: 10.4236/oalib.1102310, PP. 1-8

Subject Areas: Hematology

Keywords: Deep Vein Thrombosis, Pulmonary Embolism, EPCR, rs867186, rs9574, Sudanese

Full-Text   Cite this paper   Add to My Lib

Abstract

Background: Deep venous thrombosis (DVT) can lead to a serious fatal pulmonary embolism. Many genetic risk factors may predispose to DVT; one of these is the mutation in the PROCR gene responsible for the production of endothelial protein C receptor (EPCR), which plays an important role in activation of protein C (PC). The objective of the present study was to examine the association between the rs867186 and rs9574 polymorphism in the PROCR gene and the occurrence of DVT in Sudanese individuals. Methods: A total of 100 Sudanese DVT patients and 100 apparently healthy individuals were recruited for this study. Ethylene diamine tetraacetic acie (EDTA)-anti- coagulated blood samples were collected from all participants. Genomic DNA was extracted and PROCR gene product was amplified by a standard ploymerase chain reaction (PCR) reaction. PCR products were sequenced to identify PROCR gene polymorphisms. Results: The frequency of mutated allele of rs867186 was significantly higher in the DVT patient (41%) than in healthy control (21%). The presence of mutated allele of rs867486 increases the risk of DVT 3 folds. There was no significant difference in the frequency of mutated allele of rs9574 polymorphism between the DVT patients and the healthy control subjects. Further, it does not show an increase in the risk of DVT. The adjustment of gender, ethnic group, and body mass index (BMI) does not change the significance of each single nucleotide polymorphism (SNP) as a risk factor for DVT. Conclusion: It can be concluded that Sudanese individuals carrying the mutated allele rs867186 polymorphism were at risk to develop DVT, while the mutated allele of rs9574 polymorphism is not a risk factor for DVT in Sudanese individuals.

Cite this paper

Abuagla, H. A. , Ahmed, A. O. , Bolad, A. K. and Adam, K. M. (2016). Relation between Endothelial Protein C Receptor Gene Polymorphisms rs867186 and rs9574, and the Risk of Deep Vein Thrombosis in Sudanese. Open Access Library Journal, 3, e2310. doi: http://dx.doi.org/10.4236/oalib.1102310.

References

[1]  Douketis, J.D. (2015) Deep Vein Thrombosis (DVT).
http://www.merckmanuals.com/home/heart-and-blood-vessel-disorders
/venous-disorders/deep-vein-thrombosis-dvt

[2]  Kesieme, E., Kesieme, C., Jebbin, N., Irekpita, E. and Dongo, A. (2011) Deep Vein Thrombosis: A Clinical Review. Journal of Blood Medicine, 2, 59-69.
http://dx.doi.org/10.2147/JBM.S19009
[3]  Sirlak, M., Inan, M.B., Cetintas, D. and Ozcinar, E. (2012) Risk Factors of Deep Vein Thrombosis. Cheng, G., Ed., InTech, 1.
http://www.intechopen.com/books/deep-vein-thrombosis/risk-factors-of-deep-vein-thrombosis
[4]  Rosendaal, F.R. and Reitsma, P.H. (2009) Genetics of Venous Thrombosis. Journal of Thrombosis and Haemostasis, 7, 301-304.
http://dx.doi.org/10.1111/j.1538-7836.2009.03394.x
[5]  Wong, P. and Baglin, T. (2012) Epidemiology, Risk Factors and Sequelae of Venous Thromboembolism. Phlebology, 27, 2-11.
http://dx.doi.org/10.1258/phleb.2012.012S31
[6]  Fukudome, K. and Esmon, C.T. (1994) Identification, Cloning, and Regulation of a Novel Endothelial Cell Protein C/ Activated Protein C Receptor. Journal of Biological Chemistry, 269, 26486-26491.
[7]  Kurosawa, S., Stearns-Kurosawa, D.J., Hidari, N. and Esmon, C.T. (1997) Identification of Functional Endothelial Protein C Receptor in Human Plasma. Journal of Clinical Investigation, 100, 411-418.
http://dx.doi.org/10.1172/JCI119548
[8]  Raife, T.J. and Lentz, S.R. (2005) The Benefits of Excess EPCR. Thrombosis and Haemostasis, 3, 1349-1350.
http://dx.doi.org/10.1111/j.1538-7836.2005.01462.x
[9]  Saposnik, B., Reny, J.L., Gaussem, P., Emmerich, J., Aiach, M. and Gandrille, S. (2004) A Haplotype of the EPCR Gene Is Associated with Increased Plasma Levels of sEPCR and Is a Candidate Risk Factor for Thrombosis. Blood, 103, 1311-1318.
http://dx.doi.org/10.1182/blood-2003-07-2520
[10]  Uitte de, W.S., Van, M.V., Rosendaal, F.R., Vos, H.L., De Visser, M.C. and Bertina, R.M. (2004) Haplotypes of the EPCR Gene, Plasma sEPCR Levels and the Risk of Deep Venous Thrombosis. Journal of Thrombosis and Haemostasis, 2, 1305-1310.
http://dx.doi.org/10.1046/j.1538-7836.2004.00855.x
[11]  Karabiyik, A., Yilmaz, E., Egin, Y. and Akar, N. (2012) The Effects of Endothelial Protein C Receptor Gene Polymorphisms on the Plasma sEPCR Level in Venous Thrombosis Patients. Turkish Journal of Hematology, 29, 55-62.
[12]  Ducros, E., Mirshahi, S.S., Faussat, A.M., Mirshahi, P., Dimicoli, S., Tang, R., et al. (2012) Soluble Endothelial Protein C Receptor (sEPCR) Is Likely a Biomarker of Cancer-Associated Hypercoagulability in Human Hematologic Malignancies. Cancer Medicine, 1, 261-267.
http://dx.doi.org/10.1002/cam4.11
[13]  Abd-Elghfaar, A.A., Ismail, M.M., Farweez, B.A. and Elmasry, R.F. (2013) Influence of Soluble Endothelial Protein C Receptor (sEPCR) on Hypercoagulable State of Haemodialysis Patients. International Journal of Science and Research, 4, 1123-1128.
[14]  Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A Simple Salting out Procedure for Extracting DNA from Human Nucleated Cells. Nucleic Acids Research, 16, 1215.
http://dx.doi.org/10.1093/nar/16.3.1215
[15]  Muleledhu, A.L., Galukande, M., Makobore, P., Mwambu, T., Ameda, F. and Kiguli-Malwadde, E. (2013) Deep Venous Thrombosis after Major Abdominal Surgery in a Ugandan Hospital: A Prospective Study. International Journal of Emergency Medicine, 6, 43.
http://dx.doi.org/10.1186/1865-1380-6-43
[16]  Fall, A.O.T., Proulle, V., Sall, A., Mbaye, A., Samba Ba, P., Diao, M., et al. (2014) Risk Factors for Thrombosis in an African Population. Clinical Medical Insights: Blood Disorders, 7, 1-6.
[17]  Yin, G., Jin, X., Ming, H., Zheng, X. and Zhang, D. (2012) Endothelial Cell Protein C Receptor Gene 6936A/G Polymorphism Is Associated with Venous Thromboembolism. Experimental and Therapeutic Medicine, 3, 989-992.
[18]  Chen, X.D., Tian, L., Li, M., Jin, W., Zhang, H.K. and Zheng, C.F. (2011) Relationship between Endothelial Cell Protein C Receptor Gene 6936A/G Polymorphisms and Deep Venous Thrombosis. Chinese Medical Journal, 124, 72-75.
[19]  Navarro, S., Medina, P., Mira, Y., Estelles, A., Villa, P., Ferrando, F., et al. (2008) Haplotypes of the EPCR Gene, Prothrombin Levels, and the Risk of Venous Thrombosis in Carriers of the Prothrombin G20210A Mutation. Haematologica, 93, 885-891.
http://dx.doi.org/10.3324/haematol.12448
[20]  Chen, X.D., Tian, L., Zheng, C.F., Li, M., Jin, W., Wang, X.H., et al. (2010) Relationship between Endothelial Protein C Receptor Gene 6936A/G Polymorphisms and Deep Venous Thrombosis. Chinese Journal of Hematology, 31, 607- 609.
[21]  Dennis, J., Johnson, C.Y., Adediran, A.S., de Andrade, M., Heit, J.A., Morange, P.E., et al. (2012) The Endothelial Protein C Receptor (PROCR) Ser219Gly Variant and Risk of Common Thrombotic Disorders: A HuGE Review and Meta-Analysis of Evidence from Observational Studies. Blood, 119, 2392-2400.
http://dx.doi.org/10.1182/blood-2011-10-383448
[22]  Yamagishi, K., Cushman, M., Heckbert, S.R., Tsai, M.Y. and Folsom, A.R. (2009) Lack of Association of Soluble Endothelial Protein C Receptor and PROCR 6936A/G Polymorphism with the Risk of Venous Thromboembolism in a Prospective Study. British Journal of Haematology, 145, 221-226.
http://dx.doi.org/10.1111/j.1365-2141.2009.07612.x
[23]  Medina, P., Navarro, S., Estelles, A., Vaya, A., Woodhams, B., Mira, Y., et al. (2004) Contribution of Polymorphisms in the Endothelial Protein C Receptor Gene to Soluble Endothelial Protein C Receptor and Circulating Activated Protein C Levels, and Thrombotic Risk. Thrombosis and Haemostasis, 91, 905-911.
http://dx.doi.org/10.1160/th03-10-0657
[24]  Qu, D., Wang, Y., Song, Y., Esmon, N.L. and Esmon, C.T. (2006) The Ser219-->Gly Dimorphism of the Endothelial Protein C Receptor Contributes to the Higher Soluble Protein Levels Observed in Individuals with the A3 Haplotype. Journal of Thrombosis and Haemostasis, 4, 229-235.
http://dx.doi.org/10.1111/j.1538-7836.2005.01676.x
[25]  Saposnik, B., Lesteven, E., Lokajczyk, A., Esmon, C.T., Aiach, M. and Gandrille, S. (2008) Alternative mRNA Is Favored by the A3 Haplotype of the EPCR Gene PROCR and Generates a Novel Soluble form of EPCR in Plasma. Blood, 111, 3442-3451.
http://dx.doi.org/10.1182/blood-2007-08-104968
[26]  Medina, P., Navarro, S., Estelles, A., Vaya, A., Bertina, R.M. and Espana, F. (2005) Influence of the 4600A/G and 4678G/C Polymorphisms in the Endothelial Protein C Receptor (EPCR) Gene on the Risk of Venous Thromboembolism in Carriers of Factor V Leiden. Thrombosis and Haemostasis, 94, 389-394.
[27]  Espana, F., Medina, P., Navarro, S., Estelles, A. and Aznar, J. (2002) Inherited Abnormalities in the Protein C Activation Pathway. Pathophysiology of Haemostasis and Thrombosis, 32, 241-244.
http://dx.doi.org/10.1159/000073573

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413